Aier Eye Hospital Group Co., Ltd. (300015.SZ)
CNY 13.97
(-0.85%)
CNY 13.97
(-0.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 6.09 Billion CNY | 28.08% |
| 2022 | 4.67 Billion CNY | 2.75% |
| 2021 | 4.48 Billion CNY | 37.65% |
| 2020 | 3.02 Billion CNY | 37.75% |
| 2019 | 2.43 Billion CNY | 41.93% |
| 2018 | 1.94 Billion CNY | 45.39% |
| 2017 | 1.37 Billion CNY | 52.65% |
| 2016 | 848.15 Million CNY | 14.69% |
| 2015 | 723.49 Million CNY | 37.73% |
| 2014 | 536.92 Million CNY | 23.83% |
| 2013 | 433.61 Million CNY | 22.79% |
| 2012 | 353.14 Million CNY | 8.23% |
| 2011 | 319.8 Million CNY | 35.23% |
| 2010 | 238.76 Million CNY | 41.14% |
| 2009 | 169.5 Million CNY | 44.47% |
| 2008 | 116.98 Million CNY | 24.78% |
| 2007 | 92.56 Million CNY | 101.06% |
| 2006 | 47.06 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 1.28 Billion CNY | 93.82% |
| 2024 Q2 | 1.73 Billion CNY | 44.68% |
| 2024 Q3 | 1.85 Billion CNY | -6.93% |
| 2023 FY | - CNY | 28.08% |
| 2023 Q3 | 1.96 Billion CNY | 42.3% |
| 2023 Q4 | 807.14 Million CNY | -58.92% |
| 2023 Q2 | 1.38 Billion CNY | 18.34% |
| 2023 Q1 | 1.16 Billion CNY | 119.57% |
| 2022 Q3 | 1.57 Billion CNY | 65.87% |
| 2022 FY | - CNY | 2.75% |
| 2022 Q1 | 978.93 Million CNY | -3.15% |
| 2022 Q2 | 950.97 Million CNY | -2.86% |
| 2022 Q4 | 531.35 Million CNY | -66.31% |
| 2021 Q3 | 1.37 Billion CNY | 42.4% |
| 2021 Q2 | 966.32 Million CNY | 26.99% |
| 2021 Q1 | 760.92 Million CNY | -27.58% |
| 2021 FY | - CNY | 37.65% |
| 2021 Q4 | 1.01 Billion CNY | -26.54% |
| 2020 Q2 | 806.61 Million CNY | 514.89% |
| 2020 Q3 | 1.27 Billion CNY | 58.18% |
| 2020 Q4 | 1.05 Billion CNY | -17.65% |
| 2020 FY | - CNY | 37.75% |
| 2020 Q1 | 131.18 Million CNY | -72.17% |
| 2019 Q3 | 765.43 Million CNY | 21.96% |
| 2019 Q1 | 450.09 Million CNY | 63.89% |
| 2019 FY | - CNY | 41.93% |
| 2019 Q4 | 471.35 Million CNY | -38.42% |
| 2019 Q2 | 627.63 Million CNY | 39.44% |
| 2018 Q1 | 354.42 Million CNY | 225.64% |
| 2018 Q3 | 574.65 Million CNY | 38.16% |
| 2018 Q4 | 274.63 Million CNY | -52.21% |
| 2018 FY | - CNY | 45.39% |
| 2018 Q2 | 415.92 Million CNY | 17.35% |
| 2017 Q3 | 467.31 Million CNY | 65.22% |
| 2017 Q4 | 108.83 Million CNY | -76.71% |
| 2017 FY | - CNY | 52.65% |
| 2017 Q1 | 213.58 Million CNY | 178.49% |
| 2017 Q2 | 282.84 Million CNY | 32.42% |
| 2016 FY | - CNY | 14.69% |
| 2016 Q1 | 169.08 Million CNY | 52.52% |
| 2016 Q2 | 190.11 Million CNY | 12.44% |
| 2016 Q3 | 260.11 Million CNY | 36.82% |
| 2016 Q4 | 76.69 Million CNY | -70.52% |
| 2015 Q4 | 110.85 Million CNY | -47.22% |
| 2015 Q3 | 210.03 Million CNY | 23.68% |
| 2015 Q2 | 169.82 Million CNY | 34.88% |
| 2015 Q1 | 125.9 Million CNY | 107.64% |
| 2015 FY | - CNY | 37.73% |
| 2014 Q2 | 110.12 Million CNY | 22.99% |
| 2014 FY | - CNY | 23.83% |
| 2014 Q4 | 60.63 Million CNY | -62.54% |
| 2014 Q3 | 161.86 Million CNY | 46.98% |
| 2014 Q1 | 89.53 Million CNY | 71.27% |
| 2013 Q4 | 52.27 Million CNY | -58.17% |
| 2013 FY | - CNY | 22.79% |
| 2013 Q1 | 67.84 Million CNY | 16.39% |
| 2013 Q2 | 72.82 Million CNY | 7.33% |
| 2013 Q3 | 124.96 Million CNY | 71.6% |
| 2012 Q1 | 67.86 Million CNY | 27.27% |
| 2012 Q4 | 58.29 Million CNY | -22.93% |
| 2012 Q3 | 75.63 Million CNY | 42.86% |
| 2012 Q2 | 52.94 Million CNY | -21.98% |
| 2012 FY | - CNY | 8.23% |
| 2011 Q3 | 76.88 Million CNY | 17.64% |
| 2011 Q1 | 52.62 Million CNY | -5.68% |
| 2011 Q2 | 65.35 Million CNY | 24.18% |
| 2011 Q4 | 53.32 Million CNY | -30.64% |
| 2011 FY | - CNY | 35.23% |
| 2010 FY | - CNY | 41.14% |
| 2010 Q2 | 44.97 Million CNY | 25.88% |
| 2010 Q1 | 35.72 Million CNY | 15.42% |
| 2010 Q3 | 53.77 Million CNY | 19.57% |
| 2010 Q4 | 55.79 Million CNY | 3.76% |
| 2009 Q1 | 24.02 Million CNY | 91.15% |
| 2009 FY | - CNY | 44.47% |
| 2009 Q4 | 30.95 Million CNY | -23.72% |
| 2009 Q3 | 40.57 Million CNY | 14.68% |
| 2009 Q2 | 35.38 Million CNY | 47.26% |
| 2008 FY | - CNY | 24.78% |
| 2008 Q3 | 30.07 Million CNY | 0.0% |
| 2008 Q4 | 12.57 Million CNY | -58.21% |
| 2007 FY | - CNY | 101.06% |
| 2006 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| C.Q. Pharmaceutical Holding Co., Ltd. | 2.55 Billion CNY | -138.35% |
| Meinian Onehealth Healthcare Holdings Co., Ltd. | 2.53 Billion CNY | -140.037% |